Latest News for SEMHF
Siemens Healthineers remains a high-conviction BUY with a reiterated €48/share price target, reflecting strong Imaging and Precision Therapy segments. I exclude Chinese recovery from my base case; growth is now driven by ex-China Imaging and Varian, with diagnostics seen as structurally impaired. 3Q26 results confirmed robust order momentum (1.3x book-to-bill), and margin strength (19.1%), and EPS guidance raised to…
The German supplier of medical equipment now expects fiscal-year revenue to grow by between 3.5% and 4.0% on a comparable basis, compared with 4.5% to 5% previously.
Medical technology firm Siemens Healthineers cut its 2026 revenue growth forecast on Friday to a range of 3.5% to 4.0%, as China's procurement policy weighs on its diagnostics business.
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for SEMHF.
Senate Trading
No Senate trades found for SEMHF.
U.S. House Trading
No House trades found for SEMHF.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.